USE OF IMMUNESUPPRESSANT RECEPTOR
BIR1 functions as an immunosuppressive receptor, and the antagonist of BIR1 has immunopotentive activity, which is able to use for preventing and/or treating a cancer, an immunodeficiency disease or an infectious disease.
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English |
Published |
03.05.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | BIR1 functions as an immunosuppressive receptor, and the antagonist of BIR1 has immunopotentive activity, which is able to use for preventing and/or treating a cancer, an immunodeficiency disease or an infectious disease. |
---|---|
Bibliography: | Application Number: US201715820748 |